Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.

Glucagon-like peptide-1 (GLP-1) is an intestinally derived insulinotropic hormone currently under investigation for use as a novel therapeutic agent in the treatment of type 2 diabetes. One of several important effects of GLP-1 is on nutrient-induced pancreatic hormone release and is mediated by bin...

Full description

Bibliographic Details
Main Authors: Gromada, J, Brock, B, Schmitz, O, Rorsman, P
Format: Journal article
Language:English
Published: 2004

Similar Items